Structural Biology in Drug Design

Drug design is an innovative process to asset new medication based on the knowledge of biological target. Drug is most commonly a small molecule that inhibits or activates the function of a biomolecule, which in turn outcomes in a therapeutic benefit to the patient. Drug design are not essential for relies on computational methods. This kind of modelling is often indicated as computer-assisted drug design. Drug design which depends on the knowledge of the 3D structure of the target is known as structure-based drug design. The main methods available for drug design are structure based drug design and ligand based drug design.

 

  • 21-1. Drug targets
  • 21-1. Computer-aided drug design
  • 21-3. Ligand-based design
  • 21-4. Structure-based design
  • 21-5. Binding site identification
  • 21-6. Scoring functions

Related Conference of Structural Biology in Drug Design

February 24-25, 2025

19th International Conference on Regenerative Repair and Medicine

Madrid, Spain
April 03-04, 2025

15th International Conference on Human Genetics and Genetic Diseases

Madrid, Spain
April 03-04, 2025

18th International Conference on Genomics & Pharmacogenomics

Madrid, Spain
April 14-15, 2025

8th Annual Conference on Stem Cell and Regenerative Medicine

Budapest, Hungary
April 29-30, 2025

3rd International Conference on Cell Science and Molecular Biology

Barcelona, Spain
May 19-20, 2025

8th Global Conference on Cell and Gene Therapy

Singapore City, Singapore
June 12-13, 2025

13th World Congress on Human Genetics and Genetic Diseases

London, UK
June 16-17, 2025

21st Global Summit on Stem Cell & Regenerative Medicine

Frankfurt, Germany
July 21-22, 2025

18th World Congress on Stem Cell Research

Barcelona, Spain
October 27-28, 2025

20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

Madrid, Spain

Structural Biology in Drug Design Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in